AM3 supplement for metabolic syndrome pilot study
Part of Hormones & metabolism clinical trials.
This study tests an oral supplement called AM3 in people with metabolic syndrome. It looks at whether the supplement can help improve sugar and fat levels in the blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with metabolic syndrome (a group of conditions like high blood sugar, belly fat, high triglycerides, and low 'good' cholesterol).
- If you take metformin, a statin, or blood pressure medication, your dose must have stayed the same for a while.
- You do not smoke and do not have a history of heavy alcohol or drug use.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You are not taking semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized nutrition plan can improve health and lower the risk of chronic diseases like diabetes and heart disease in middle-aged adults with metabolic syndrome.
This study tests a food supplement to see if it helps improve markers of metabolic syndrome, a group of conditions that raise your risk for heart disease and diabetes. It might help you by improving your cholesterol, blood sugar, or other related health measures.
This trial tests whether foods with antioxidants, prebiotic fibers, and oat beta-glucans can help people who are at risk for metabolic syndrome. It looks at measures like waist size, blood sugar, blood pressure, and cholesterol to see if these foods improve health markers.
This trial studies an herbal supplement called fenugreek (a spice seed) to see if it can help improve blood sugar, blood pressure, and cholesterol in people with metabolic syndrome. You may be asked to take the supplement or a placebo (inactive pill) for a period of time.
This trial tests whether taking probiotics can improve gut health in people with early metabolic problems related to extra body fat, cholesterol, blood pressure, or blood sugar. It’s a Phase 1/2 study, meaning safety and early effectiveness are being tested.
This trial tests whether taking a daily drink containing short-chain fatty acids can improve risk factors for metabolic syndrome, like belly fat, high blood sugar, or high blood pressure. It might help if you are at risk but not yet taking medications for these conditions.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.